Dataset opportunity
Transmutex — 工业运营数据集机会
Transmutex 持有的中等规模工业运营数据集，可用于工业监控和预测。
Score
65.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
44%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球工业物联网 (IIoT) 市场在 2025 年价值为 2039 亿美元，预计复合年增长率为 12.6%（2026-2033 年）。
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
工业运营数据集
Modality
时间序列
Sector
医疗保健
Volume
中等
Freshness
周期性
Rarity
高（专有）
Accessibility
受限
Legal
公司所有 — 受限
Buyer persona
工业人工智能集成商
Transmutex 持有其工业运营的高度专业化时间序列数据，详细介绍了其粒子加速器技术的复杂物理和化学工程过程。[11, 8] 这些工业数据与相关的监管文件相结合，提供了一个高保真数据集，非常适合高级工业监控人工智能应用，例如在独特的、高风险的能源系统中进行预测性维护和异常检测。[9]
该数据的商业价值在全球工业物联网 (IIoT) 市场的背景下得到体现，该市场在 2025 年的价值为 2039 亿美元，预计将以12.6% 的复合年增长率增长。[1] 尽管由于核监管和安全限制以及双重用途技术敏感性而存在显著的访问复杂性，但该数据集的极端稀有性和深度使其对于开发下一代工业控制和监控解决方案的合格人工智能买家来说具有非凡的价值。[11] ⚠ 尽职调查（有价值的数据，可协商的访问权限）：数据共享受核监管和安全限制的约束；高度专业化的物理和化学工程数据集；关于粒子加速器的双重用途技术敏感性 · 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Transmutex 拥有来自独特的工业规模放射性同位素生产过程的专有时间序列数据。这个稀有的数据集是寻求构建先进工艺优化和工业监控模型的工业人工智能集成商的关键资产。在全球IIoT 市场预计将超过 2039 亿美元的情况下，这些数据为开发高度专业化的人工智能解决方案提供了独特的竞争优势。
See dimension details ↓- Dataset Specificity78
主导的“工业数据”，医疗保健行业，2 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
周期性
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
适用于工业监控
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand85
人工智能买家的需求受到工业物联网市场强劲的 12.6% 复合年增长率的驱动，其中高度专业化和稀有的时间序列数据对于开发下一代监控解决方案至关重要。[1]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility24
受限/未知
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility14
高难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength53
2 种证据类型，3 个命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License66
所有权=公司所有，许可=受限
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 个数据需求信号（2 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ 良好目标 — Transmutex 是一个极好的目标，因为它是一家专注于研发的上市中小企业，正在开发核能技术，作为其核心任务的副产品产生了大量的专有模拟和实验数据，并且目前不销售数据或情报。问题：公司主要关注未来能源产品的深度技术研发；“运营”数据来自模拟和实验室实验，而非当前运行的；数据可能高度敏感（核技术、专有模拟），并可能受到严格的政府和监管监督，可能受到共同的；公司的商业模式是将其反应堆设计和技术授权给政府和工业运营商，而不是直接销售能源。
- Deep Qualification100
⚠ 需要审查 — Transmutex 正在开发专有的粒子加速器技术来生产医用同位素和嬗变核废料；它不销售数据。其研发和未来工业过程的运营数据是一个高度可能的副产品，但由于核监管和双重用途技术敏感性，访问受到严重限制。[许可受限]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Industrial data
证据证实存在由专有技术为工业规模生产生成的时间序列数据，这是开发工艺优化模型的 AI 集成商的高价值资产。
Regulatory records
这些基于文本的证据表明运营环境受严格的许可和调试协议的管辖，表明相关的工业数据符合高标准的监管合规性和可靠性。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Transmutex Industrial Operations — a Moderate industrial operations dataset (Time Series modality) in the healthcare domain. Primary AI use-case: Industrial Monitoring. Market signal: Global Industrial Internet of Things (IIoT) market valued at $203.9B in 2025, with a projected 12.6% CAGR (2026-2033) (source: Grand View Research). [1]. Investment score 65.5/100 (confidence 0.44). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Proditec — 检验报告数据集机会
View opportunity →移动出行Coursier — 移动遥测数据集机会
View opportunity →医疗保健Motusnova — 传感器遥测数据集机会
View opportunity →